Company Filing History:
Years Active: 2025
Title: Jodi McGill: Innovator in Immunogenic Compositions
Introduction
Jodi McGill is a notable inventor based in Manhattan, Kansas. She has made significant contributions to the field of immunology, particularly in developing compositions aimed at combating diseases associated with tick-borne pathogens. Her innovative work has the potential to enhance animal health and welfare.
Latest Patents
Jodi McGill holds 1 patent for her invention related to immunogenic compositions and methods of using them. The patent provides compositions and methods for reducing the incidence and severity of diseases caused by tick-borne pathogens. The compositions include a recombinant antigenic protein subunit that has been glycosylated. Notable subunits in her invention include the MAP1 protein, the p30-1 sequence, the p28-Omp19 protein, and the MSP4 protein. Administering these compositions to susceptible animals offers protection against clinical signs of infection.
Career Highlights
Jodi McGill is affiliated with the Kansas State University Research Foundation, where she continues her research and development efforts. Her work is instrumental in advancing the understanding of immunogenic responses and developing effective solutions for animal health.
Collaborations
Jodi collaborates with Bonto Faburay, who is also involved in research related to immunogenic compositions. Their partnership enhances the scope and impact of their research initiatives.
Conclusion
Jodi McGill's innovative contributions to immunogenic compositions demonstrate her commitment to improving animal health through scientific research. Her work is paving the way for advancements in the field of immunology.